| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |